APO Research
Talk to an analyst

APO RESEARCH · REPORT

Riluzole Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Riluzole Tablet Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchRiluzole Tablet Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Riluzole Tablet Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Riluzole Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Riluzole Tablet Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Riluzole Tablet Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Riluzole Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Riluzole Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Riluzole Tablet market include Apotex, Covis Pharma, Glemark Generics, Italfarmaco, Lunan Pharma, Mylan Pharma, Sanofi and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Riluzole Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Riluzole Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Riluzole Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Riluzole Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Riluzole Tablet Segment by Company

Apotex

Covis Pharma

Glemark Generics

Italfarmaco

Lunan Pharma

Mylan Pharma

Sanofi

Sun Pharma

Riluzole Tablet Segment by Type

With Film-coated

Without Film-coated

Riluzole Tablet Segment by Application

Hospital

Pharmacy

Riluzole Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Riluzole Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Riluzole Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Riluzole Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Riluzole Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riluzole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Riluzole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riluzole Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Riluzole Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Riluzole Tablet industry.

Chapter 3: Detailed analysis of Riluzole Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Riluzole Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Riluzole Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Riluzole Tablet Industry Trends Table 2. Riluzole Tablet Industry Drivers Table 3. Riluzole Tablet Industry Opportunities and Challenges Table 4. Riluzole Tablet Industry Restraints Table 5. Global Riluzole Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Riluzole Tablet Revenue Share by Company (2021-2026) Table 7. Global Riluzole Tablet Sales Volume by Company (k units) & (2021-2026) Table 8. Global Riluzole Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Riluzole Tablet Average Price (US$/unit) of Company (2021-2026) Table 10. Global Riluzole Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Riluzole Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Riluzole Tablet Company, Product Type & Application Table 13. Global Riluzole Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Riluzole Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of With Film-coated Table 18. Significant Companies of Without Film-coated Table 19. Global Riluzole Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Riluzole Tablet Sales Volume by Type (2021-2026) & (k units) Table 21. Global Riluzole Tablet Sales Volume by Type (2027-2032) & (k units) Table 22. Global Riluzole Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Riluzole Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Riluzole Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Riluzole Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Riluzole Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Riluzole Tablet Sales Value Share by Type (2021-2026) Table 28. Global Riluzole Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Global Riluzole Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Riluzole Tablet Sales Volume by Application (2021-2026) & (k units) Table 33. Global Riluzole Tablet Sales Volume by Application (2027-2032) & (k units) Table 34. Global Riluzole Tablet Sales Volume Share by Application (2021-2026) Table 35. Global Riluzole Tablet Sales Volume Share by Application (2027-2032) Table 36. Global Riluzole Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Riluzole Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Riluzole Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Riluzole Tablet Sales Value Share by Application (2021-2026) Table 40. Global Riluzole Tablet Sales Value Share by Application (2027-2032) Table 41. Global Riluzole Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Riluzole Tablet Sales by Region (2021-2026) & (k units) Table 43. Global Riluzole Tablet Sales Market Share by Region (2021-2026) Table 44. Global Riluzole Tablet Sales by Region (2027-2032) & (k units) Table 45. Global Riluzole Tablet Sales Market Share by Region (2027-2032) Table 46. Global Riluzole Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Riluzole Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Riluzole Tablet Sales Value Share by Region (2021-2026) Table 49. Global Riluzole Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Riluzole Tablet Sales Value Share by Region (2027-2032) Table 51. Global Riluzole Tablet Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Riluzole Tablet Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Riluzole Tablet Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Riluzole Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Riluzole Tablet Sales by Country (2021-2026) & (k units) Table 56. Global Riluzole Tablet Sales Market Share by Country (2021-2026) Table 57. Global Riluzole Tablet Sales by Country (2027-2032) & (k units) Table 58. Global Riluzole Tablet Sales Market Share by Country (2027-2032) Table 59. Global Riluzole Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Riluzole Tablet Sales Value Market Share by Country (2021-2026) Table 61. Global Riluzole Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Riluzole Tablet Sales Value Market Share by Country (2027-2032) Table 63. Apotex Company Information Table 64. Apotex Business Overview Table 65. Apotex Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Apotex Riluzole Tablet Product Portfolio Table 67. Apotex Recent Development Table 68. Covis Pharma Company Information Table 69. Covis Pharma Business Overview Table 70. Covis Pharma Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Covis Pharma Riluzole Tablet Product Portfolio Table 72. Covis Pharma Recent Development Table 73. Glemark Generics Company Information Table 74. Glemark Generics Business Overview Table 75. Glemark Generics Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Glemark Generics Riluzole Tablet Product Portfolio Table 77. Glemark Generics Recent Development Table 78. Italfarmaco Company Information Table 79. Italfarmaco Business Overview Table 80. Italfarmaco Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Italfarmaco Riluzole Tablet Product Portfolio Table 82. Italfarmaco Recent Development Table 83. Lunan Pharma Company Information Table 84. Lunan Pharma Business Overview Table 85. Lunan Pharma Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Lunan Pharma Riluzole Tablet Product Portfolio Table 87. Lunan Pharma Recent Development Table 88. Mylan Pharma Company Information Table 89. Mylan Pharma Business Overview Table 90. Mylan Pharma Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Mylan Pharma Riluzole Tablet Product Portfolio Table 92. Mylan Pharma Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Sanofi Riluzole Tablet Product Portfolio Table 97. Sanofi Recent Development Table 98. Sun Pharma Company Information Table 99. Sun Pharma Business Overview Table 100. Sun Pharma Riluzole Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Sun Pharma Riluzole Tablet Product Portfolio Table 102. Sun Pharma Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Riluzole Tablet Distributors List Table 106. Riluzole Tablet Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Riluzole Tablet Product Image Figure 2. Global Riluzole Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Riluzole Tablet Sales (2021-2032) & (k units) Figure 5. Global Riluzole Tablet Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Riluzole Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. With Film-coated Image Figure 10. Without Film-coated Image Figure 11. Global Riluzole Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Riluzole Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Riluzole Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Riluzole Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Riluzole Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Riluzole Tablet Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Riluzole Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Riluzole Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Riluzole Tablet Sales Volume Share by Application (2021-2032) Figure 22. Global Riluzole Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Riluzole Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Riluzole Tablet Sales Value Share by Application (2021-2032) Figure 25. Global Riluzole Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Riluzole Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Riluzole Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Riluzole Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 30. North America Riluzole Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Riluzole Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Riluzole Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 36. South America Riluzole Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Riluzole Tablet Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Riluzole Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Riluzole Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Riluzole Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Riluzole Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Riluzole Tablet Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Riluzole Tablet Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • With Film-coated
  • Without Film-coated
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Apotex
  • Covis Pharma
  • Glemark Generics
  • Italfarmaco
  • Lunan Pharma
  • Mylan Pharma
  • Sanofi
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Riluzole Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Riluzole Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Riluzole Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Riluzole Tablet Market Dynamics
  1. 2.1 Riluzole Tablet Industry Trends
  2. 2.2 Riluzole Tablet Industry Drivers
  3. 2.3 Riluzole Tablet Industry Opportunities and Challenges
  4. 2.4 Riluzole Tablet Industry Restraints
3 Riluzole Tablet Market by Company
  1. 3.1 Global Riluzole Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Riluzole Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Riluzole Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Riluzole Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Riluzole Tablet Company Ranking (2024-2026)
  6. 3.6 Global Riluzole Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Riluzole Tablet Company Product Type and Application
  8. 3.8 Global Riluzole Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Riluzole Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Riluzole Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Riluzole Tablet Market by Type
  1. 4.1 Riluzole Tablet Type Introduction
  2. 4.1.1 With Film-coated
  3. 4.1.2 Without Film-coated
  4. 4.2 Global Riluzole Tablet Sales Volume by Type
  5. 4.2.1 Global Riluzole Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Riluzole Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Riluzole Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Riluzole Tablet Sales Value by Type
  9. 4.3.1 Global Riluzole Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Riluzole Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Riluzole Tablet Sales Value Share by Type (2021-2032)
5 Riluzole Tablet Market by Application
  1. 5.1 Riluzole Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Riluzole Tablet Sales Volume by Application
  5. 5.2.1 Global Riluzole Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Riluzole Tablet Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Riluzole Tablet Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Riluzole Tablet Sales Value by Application
  9. 5.3.1 Global Riluzole Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Riluzole Tablet Sales Value by Application (2021-2032)
  11. 5.3.3 Global Riluzole Tablet Sales Value Share by Application (2021-2032)
6 Riluzole Tablet Regional Sales and Value Analysis
  1. 6.1 Global Riluzole Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Riluzole Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Riluzole Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Riluzole Tablet Sales by Region (2027-2032)
  5. 6.3 Global Riluzole Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Riluzole Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Riluzole Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Riluzole Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Riluzole Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Riluzole Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Riluzole Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Riluzole Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Riluzole Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Riluzole Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Riluzole Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Riluzole Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Riluzole Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Riluzole Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Riluzole Tablet Sales Value Share by Country, 2025 VS 2032
7 Riluzole Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Riluzole Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Riluzole Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Riluzole Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Riluzole Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Riluzole Tablet Sales by Country (2027-2032)
  6. 7.4 Global Riluzole Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Riluzole Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Riluzole Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Riluzole Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Riluzole Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Riluzole Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Riluzole Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Riluzole Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Riluzole Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Riluzole Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Riluzole Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Riluzole Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Riluzole Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Riluzole Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Riluzole Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Riluzole Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Riluzole Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Riluzole Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Riluzole Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Riluzole Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Riluzole Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Riluzole Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Riluzole Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Riluzole Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Riluzole Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Riluzole Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Riluzole Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Riluzole Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Riluzole Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Riluzole Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Riluzole Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Riluzole Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Riluzole Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Apotex
  2. 8.1.1 Apotex Company Information
  3. 8.1.2 Apotex Business Overview
  4. 8.1.3 Apotex Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Apotex Riluzole Tablet Product Portfolio
  6. 8.1.5 Apotex Recent Developments
  7. 8.2 Covis Pharma
  8. 8.2.1 Covis Pharma Company Information
  9. 8.2.2 Covis Pharma Business Overview
  10. 8.2.3 Covis Pharma Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Covis Pharma Riluzole Tablet Product Portfolio
  12. 8.2.5 Covis Pharma Recent Developments
  13. 8.3 Glemark Generics
  14. 8.3.1 Glemark Generics Company Information
  15. 8.3.2 Glemark Generics Business Overview
  16. 8.3.3 Glemark Generics Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glemark Generics Riluzole Tablet Product Portfolio
  18. 8.3.5 Glemark Generics Recent Developments
  19. 8.4 Italfarmaco
  20. 8.4.1 Italfarmaco Company Information
  21. 8.4.2 Italfarmaco Business Overview
  22. 8.4.3 Italfarmaco Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Italfarmaco Riluzole Tablet Product Portfolio
  24. 8.4.5 Italfarmaco Recent Developments
  25. 8.5 Lunan Pharma
  26. 8.5.1 Lunan Pharma Company Information
  27. 8.5.2 Lunan Pharma Business Overview
  28. 8.5.3 Lunan Pharma Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Pharma Riluzole Tablet Product Portfolio
  30. 8.5.5 Lunan Pharma Recent Developments
  31. 8.6 Mylan Pharma
  32. 8.6.1 Mylan Pharma Company Information
  33. 8.6.2 Mylan Pharma Business Overview
  34. 8.6.3 Mylan Pharma Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Pharma Riluzole Tablet Product Portfolio
  36. 8.6.5 Mylan Pharma Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Riluzole Tablet Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Riluzole Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Riluzole Tablet Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Riluzole Tablet Value Chain Analysis
  2. 9.1.1 Riluzole Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Riluzole Tablet Sales Mode & Process
  6. 9.2 Riluzole Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Riluzole Tablet Distributors
  9. 9.2.3 Riluzole Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst